Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma (DLBCL), according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting (September 24-27, 2017; San Diego, CA).

Read More

News

Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma (DLBCL), according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting (September 24-27, 2017; San Diego, CA).

Read More

A recent analysis examined the potential correlation between preexisting cardiovascular conditions and risk of heart failure in survivors of non-Hodgkin lymphoma, published in the Journal of Clinical Oncology (online September 18, 2017; doi:10.1200/JCO.2017.72.4211).

Read More

Following a recent literature review, a team of researchers have proposed new guidelines for the systematic management of side effects associated with chimeric antigen receptor T (CAR-T) cell treatment.

The guidelines involve the use of a new algorithm, which can help maintain patient safety as researchers continue to develop and tailor the relatively new CAR-T cell therapies.

Read More

A model that incorporates patient-specific characteristics for those with acute myeloid leukemia (AML) may help predict mortality after treatment, according to an investigation published in JAMA Oncology (online September 7, 2017;doi:10.1001/jamaoncol.2017.2714).

Read More

Quiz

A recently developed model for AML was found to accurately predict which outcome after treatment?

According to a report published in the Journal of Translational Medicine, elevated expression levels of what gene translates to a poor prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions?

-----

A. ETS2

B. CEBPA

C. PML

D. RARA

-----

Read More

Research in Review

Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One (published online March 29, 2017; doi:10.1371/journal.pone.0174648).

-----

Related Content

Read More

Patients with mantle cell lymphoma (MCL) benefit from prolonged event-free survival (EFS) and overall survival (OS) when treated with autologous stem cell transplantation (ASCT) and total body irradiation, according to a report published in Radiation and Oncology (March 1, 2017;51[1]:81-87).

-----

Related Content

Read More

Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and Blood Disorders was established as part of the LCI in an effort to bring subspecialized care in malignant and nonmalignant hematology to the region.

Read More

Subscribe to Blood Cancer